Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high ...
A recent article in the Annals of Emergency Medicine reported on the diagnostic accuracy of the newly released Beckman C...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, and Antengene Corporation, a biopharmaceutical company, recen...
Puma Biotechnology, Inc., a biopharmaceutical company, and Strata Oncology, Inc., a precision oncology company, have ent...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...
